A review of injectable medicines on the Model List was presented.1 Of the 306 medicines that are currently on the Model List, 135 (44%) are listed as injectable medicines in 173 presentations. Of these, 41 require reconstitution, implying the need for diluents. In view of the problems associated with the use of injections mentioned previously (see section 4.4), the Committee recommended that a review of all injectable medicines on the Model List be carried out. The aim of such a review would be to reduce the total number of medicines listed as injectable forms in favour of other administration routes and/or dosage forms, wherever possible.
1 Available from the WHO Essential Medicines Library via the Internet at http://mednet3.who.int/mf/.